Literature DB >> 23809716

Methicillin-resistant Staphylococcus aureus infections.

Paul S Pottinger1.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen that has exploded into clinical prominence in a short period. New medications are available for the treatment of MRSA infections, each with its own pitfalls and caveats. However, the resistance profile of the bacteria is becoming more complex. Recent guidelines from the Infectious Diseases Society of America provide an evidence-based framework for the management of MRSA infections. This article provides additional practical advice on approaches to MRSA, including the detection, prevention, and management of a variety of its common presentations.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23809716     DOI： 10.1016/j.mcna.2013.02.005

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  14 in total

1.  A Novel Surgical Approach to Nasolabial Fistula.

Authors:  Gautham Ullas; K V Vishwas; B M Joshna
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-01-30

2.  Comparison of ESwab with traditional swabs for detection of methicillin-resistant Staphylococcus aureus using two different walk-away commercial real-time PCR methods.

Authors:  Suzane Silbert; Carly Kubasek; Dominic Uy; Raymond Widen
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

3.  Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction patients.

Authors:  Katsumi Shigemura; Kayo Osawa; Fukashi Yamamichi; Kazushi Tanaka; Issei Tokimatsu; Soichi Arakawa; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2015-04-22       Impact factor: 2.370

4.  Peritoneal GATA6+ macrophages function as a portal for Staphylococcus aureus dissemination.

Authors:  Selina K Jorch; Bas Gj Surewaard; Mokarram Hossain; Moritz Peiseler; Carsten Deppermann; Jennifer Deng; Ania Bogoslowski; Fardau van der Wal; Abdelwahab Omri; Michael J Hickey; Paul Kubes
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

5.  Antibacterial, antioxidant, antifungal and anti-inflammatory activities of crude extract from Nitraria schoberi fruits.

Authors:  Javad Sharifi-Rad; Seyedeh Mahsan Hoseini-Alfatemi; Majid Sharifi-Rad; Jaime A Teixeira da Silva
Journal:  3 Biotech       Date:  2014-11-13       Impact factor: 2.406

6.  Structural and functional characterization of methicillin-resistant Staphylococcus aureus's class IIb fructose 1,6-bisphosphate aldolase.

Authors:  Glenn C Capodagli; Stephen A Lee; Kyle J Boehm; Kristin M Brady; Scott D Pegan
Journal:  Biochemistry       Date:  2014-11-21       Impact factor: 3.162

7.  Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature.

Authors:  Elzbieta Kolaczkowska; Craig N Jenne; Bas G J Surewaard; Ajitha Thanabalasuriar; Woo-Yong Lee; Maria-Jesus Sanz; Kerri Mowen; Ghislain Opdenakker; Paul Kubes
Journal:  Nat Commun       Date:  2015-03-26       Impact factor: 14.919

Review 8.  Recurrent furunculosis - challenges and management: a review.

Authors:  Kristina Sophie Ibler; Charles B Kromann
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-02-18

9.  Climatic factors and community - associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections - a time-series analysis study.

Authors:  Krushna Chandra Sahoo; Soumyakanta Sahoo; Gaetano Marrone; Ashish Pathak; Cecilia Stålsby Lundborg; Ashok J Tamhankar
Journal:  Int J Environ Res Public Health       Date:  2014-08-29       Impact factor: 3.390

10.  Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms.

Authors:  María Lázaro-Díez; Sara Remuzgo-Martínez; Cristina Rodríguez-Mirones; Felix Acosta; Jose M Icardo; Luis Martínez-Martínez; José Ramos-Vivas
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.